Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival

Conclusions Long-term regional chemotherapy was associated with improved survival in patients with MPM. In this rare disease, additional phase 2 investigations are suggested. Teaser Synopsis: Malignant peritoneal mesothelioma was treated over a 20 year time period with a consistent surgical procedure followed by an escalation of regional chemotherapy treatments. When regional chemotherapy long term was added to the treatment plan survival improved significantly (p=0.0108).
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research